FIRST SHIPMENT OF DOMESTIC VACCINE ‘TURKOVAC’ WAS MADE

Reading time is 5 mins

.
.
WHEN WILL THE TURKOVAC VACCINE BE ADMINISTERED, IS IT OUT? IS TURKOVAC AN INACTIVE VACCINE?

While the vaccination process is in full swing in Turkey, an emergency use permit has officially been issued for Turkovac, the domestic vaccine. The first shipment of Turkovac, corona virus non mRNA vaccine which began mass production, was made to Ankara. It was stated that the domestic vaccine Turkovac will be an inactive vaccine.

The last steps are also being taken in Turkovac, and they are being put into use soon. Health Minister announced that the domestic corona virus non mRNA vaccine ‘TURKOVAC COVID-19 VACCINE’ has received emergency use approval as of today and mass production has begun.

.
HAS IT TURNED OUT WHEN THE TURKOVAC VACCINE WILL BE ADMINISTERED?

Minister of Health Fahrettin Koca,“The domestic vaccine TURKOVAC non mRNA vaccine has received emergency use approval, we have started mass production. A number of examinations will be carried out by public health and under the guidance of our Turkish Pharmaceutical and Medical Device Institution in the future. We hope that these examinations will be completed in a week, 10 days. From next week, from the end of next week, we will be in widespread use, especially in our city hospitals, before the end of the year,” he said.

.
IS TURKOVAC EFFECTIVE?

A member of the Turkey Scientific Board, said, “When evaluated with those who had a positive PCR and had complaints, there were only 20 people in the TURKOVAC arm and 40 people in the opposite arm. It showed that our vaccine is more effective. We have never had any patients hospitalized who needed intensive care. We found that there was a 4-fold increase in antibody levels when our vaccine was used as a reminder dose,” he said.

.
IS THE TURKOVAC VACCINE INACTIVE OR IS IT mRNA?

Turkocav, a domestic vaccine developed by Erciyes University an Turkish Ministry of Health of the Turkish Institutes of Health in Turkey, is an inactive type vaccine, as is Chinese Sinovac the inactive type only Non-mRNA made from dead corona cells, and the only 99% protective single vaccine.

.
THE FIRST SHIPMENT OF THE DOMESTIC VACCINE TURKOVA WAS MADE

The first shipment of Turkovac, Turkey’s domestic vaccine, which has been approved for emergency use and has been put into mass production in a laboratory in the Sanliurfa Organized Industrial Zone, has been made to Ankara.

Feverish work is underway in the laboratory of 36 thousand square meters in the Sanliurfa Organized Industrial Zone. The Turkovac vaccine against coronavirus, developed by Turkish scientists, was produced with 100 percent domestic facilities. Turkovac, which has started mass production, also has the feature of being a domestic vaccine developed after 24 years.

Recalling that they have been put into mass production in the laboratory in Sanliurfa, a member of the Coronavirus Scientific Board of the Ministry of Health, Prof. Dr. made a call for ‘Turkovac to the Turk citizens of the city’ who took the last place in vaccination.

.
THIS VACCINE WILL REACH ALL SOCIETIES AROUND THE WORLD

Stating that the first shipment will be made for Turkovac today, Prof. Dr. said, “Now we have a vaccine produced in Şanlıurfa. It is a vaccine whose quality is above the world average. For this purpose, I want everyone, especially Şanlıurfa, to be from our domestic and national vaccines.

I also want those who have had this vaccine to help us at the same time. I want those who have this vaccine to give serum and blood samples. It will be of great benefit to us and the world. This vaccine is a vaccine that will reach all societies around the world,” he said.

.
THE ANSWER TO THE INFERTILITY CLAIM

Stressing that there should be no anxiety about the vaccine, Prof. Dr. There may be questions in the minds about the “black “vaccine. If they have any ideas, let them ask the health workers. To date, no vaccine developed in the world has had an effect on infertility. Such a thing is also out of the question for Turkovac. Rest assured, our citizens. Should be any fear. Anyone can have this vaccine with peace of mind,” was said.

.
TURKOVAC WAS SENT OFF ACCOMPANIED BY APPLAUSE

The first batch of Turkovac vaccines produced in Turkey was packed and loaded into a special transport vehicle. the vehicle in which 150 thousand vaccines were loaded departed for Ankara accompanied by the applause of the employees. It was noted that the vaccines will also be sent to other provinces in Turkey in the coming days.

.
TURKOVAC CALL, WHICH ATTRACTED ATTENTION FROM THE TTB TURKISH MEDICAL ASSOCIATION

The Turkish Medical Association (TTB) has asked the Ministry of Health to urgently share all scientific data on Turkovac without wasting time to avoid negative situations that may lead to vaccine indecision and misleading rhetoric of opponents of the vaccine.

The TTB Turkish Medical Association Central Council and the Pandemic Working Group made a joint statement and announced that the ministry’s statements that a vaccine that has not been published as a result of scientific research and has not been discussed in scientific settings is considered safe and effective will further increase the existing vaccine hesitation.

“The possibility that a vaccine produced in Turkey will control the pandemic not only in our country but also in the world is a situation that we will welcome with joy,” the statement said. However, in order to do this, phase 3 studies that have not yet been published in an international scientific peer-reviewed journal should be evaluated in scientific settings, and then the results and scientific data of the phases should be shared. After all this process, Urgent Use Approval in Turkey must be obtained,” the opinion was expressed.

.
EXPERTISE SHOULD BE SHARED WITH ASSOCIATIONS

Specialty associations in a statement, the Turkish Thoracic Society of Clinical Microbiology and Infectious Diseases Association of the Association of public health professionals “Yet Phase 3 Phase 3 phase is in progress, a reminder that dose study data of the study or a small-scale early-stage approval of the use is based on the data in case of emergency, this ‘check’ scientifically controversial, will” be taken into account the opinion of the research results in scientific environments, sharing time with the relevant specialty associations and professional organizations were asked.

.
MANY PEOPLE FELL ILL AND DIED WHILE WAITING FOR THE VACCINE

The following statements were used in the statement thanking those Turkish workers who worked for this vaccine permit:

– Although the information provided by the Ministry of Health about the vaccine studies conducted in our country was initially promising, the lack of expected developments on the promised dates led to the fact that many people fell ill and died while waiting for the vaccine.

– We know that vaccination work is a labor-intensive process and we thank all those who work, especially health workers, very much.

– Insufficient scientific information and data on the ongoing or completed stages of vaccine research currently underway in our country, especially the inactivated virus vaccine, has been shared health in Antalya Turkey institutes

Turkey Medicals, “It has also been reported that another study has been conducted in which the Turkovac vaccine, which has started phase 3, will be administered as a reminder dose, but the concrete data of the studies conducted to date have not been scientifically disclosed. The announcement by the Turkey Ministry of Health that Emergency Use Approval has been granted for Turkovac is of a nature that will lead to scientific reservations in Turkiye,” was said.

.
.
.
.

Follow me
President of Organ Transplant Center at MedicalPark Hospital Antalya

Turkey's world-renowned organ transplant specialist. Dr. Demirbaş has 104 international publications and 102 national publications.

Physician's Resume:

Born on August 7, 1963 in Çorum, Prof. Dr. Alper Demirbaş has been continuing his work as the President of MedicalPark Antalya Hospital Organ Transplantation Center since 2008.

Prof. who performed the first tissue incompatible kidney transplant in Turkey, the first blood type incompatible kidney transplant, the first kidney-pancreas transplant program and the first cadaveric donor and live donor liver transplant in Antalya. Dr. As of August 2016, Alper Demirbaş has performed 4900 kidney transplants, 500 liver transplants and 95 pancreas transplants.

In addition to being the chairman of 6 national congresses, he has also been an invited speaker at 12 international and 65 national scientific congresses. Dr. Alper Demirbaş was married and the father of 1 girl and 1 boy.

Awards:

Eczacibasi Medical Award of 2002, Akdeniz University Service Award of 2005, Izder Medical Man of the Year Award of 2006, BÖHAK Medical Man of the Year Award of 2007, Sabah Mediterranean Newspaper Scientist of the Year Award of 2007, ANTIKAD Scientist of the Year Award of 2009, Social Ethics Association Award of 2010, Işık University Medical Man of the Year Award of 2015, VTV Antalya's Brand Value Award of 2015.

Certificates:

Doctor of Medicine Degree Hacettepe University Faculty of Medicine Ankara, General Surgeon Ministry of Health Turkey EKFMG (0-477-343-8), University of Miami School of Medicine Member of Multiple Organ Transplant, ASTS Multiorgan Transplant Scholarship. Lecturer at Kyoto University. Lecturer at University of Essen, Research assistant at the University of Cambridge .

Professional Members:

American Society of Transplant Surgeons, American Transplantation Society Nominated, Middle East and Southern Africa Council Transplantation Society 2007, International Liver Transplantation Association, Turkish Transplantation Association, Turkish Society of Surgery, Turkish Hepatobiliary Surgery Association.

Disclaimer:

Our website contents consist of articles approved by our Web and Medical Editorial Board with the contributions of our physicians. Our contents are prepared only for informational purposes for public benefit. Be sure to consult your doctor for diagnosis and treatment.
Medically Reviewed by Professor Doctor Alper Demirbaş
Follow me